PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
- Citation:
- J Clin Oncol vol 42 (10) 1114-23
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Janssen Scientific Affairs, LLC
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Glenn Heller David W Hillman Han Xiao Joel Picus Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin James Mohler Daniel Anderson Arpit Rao Scott Tagawa Alan Tan Susan Halabi Katharine Dooley Patrick O'Brien Ronald Chen Charles J Ryan Scott E Eggener Michael J Morris
- Networks:
- CA043, CA824, IL018, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TN008, METROMIN, MN022, NH038, NY018, TX041
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: